- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 279/24 - Y étant un hétéro-atome
Détention brevets de la classe C07C 279/24
Brevets de cette classe: 43
Historique des publications depuis 10 ans
4
|
7
|
7
|
4
|
3
|
0
|
4
|
4
|
1
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Modernatx, Inc. | 1284 |
8 |
Lantheus Medical Imaging, Inc. | 177 |
4 |
Nippon Soda Co., Ltd. | 894 |
3 |
Farmington Pharma Development | 7 |
2 |
Trioptotec GmbH | 17 |
2 |
The Regents of the University of California | 20059 |
1 |
FUJIFILM Corporation | 29543 |
1 |
Kaneka Corporation | 4566 |
1 |
JPMorgan Chase Bank, National Association | 8570 |
1 |
Cellix Bio Private Limited | 52 |
1 |
Cortexyme, Inc | 11 |
1 |
The Florida International University Board of Trustees | 625 |
1 |
Fox Chase Chemical Diversity Center, Inc. | 14 |
1 |
Immunomet Therapeutics Inc. | 31 |
1 |
National University Corporation Tokyo University of Agriculture and Technology | 341 |
1 |
Newsouth Innovations Pty Limited | 598 |
1 |
Otsuka America Pharmaceutical, Inc. | 70 |
1 |
Quanta BioDesign, Ltd. | 4 |
1 |
Regents of the University of Minnesota | 2699 |
1 |
Sekisui Medical Co., Ltd. | 662 |
1 |
Autres propriétaires | 9 |